Thursday, August 28, 2014

Panel on brand-name and generics manufacturers liability

Yesterday I posted a comment on a recent decision from the Alabama Supreme Court on the possible liability of a brand-name drug manufacturer for injuries related to defective warnings provided by a generics drug manufacturer.   Looking for some information on the topic I found the video that appears below of a panel at a conference on the subject.  I just found it a few minutes ago and I have not had a chance to watch it, so I can't comment on it.  (One note:  when the panelists (or the literature) uses the term "innovator" they are referring to the "name-brand manufacturer.")  Here is the video:

No comments: